logo

For the Inventor, By the Inventor

Shizuoka, Japan

Yoshiyuki Nakamura

This inventor holds 6 USPTO granted patents. Top assignees: Senju Pharmaceutical Co., Ltd., The Green Cross Corporation, Sapporo Breweries Limited. Active years: 1993-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyuki Nakamura. Retrieved from https://idiyas.com/inventor/yoshiyuki-nakamura-eowu4in3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal5 out of 229 
 
Senju Pharmaceutical Co., Ltd.
 patents
silverMedal5 out of 264 
 
The Green Cross Corporation
 patents
bronzeMedal1 out of 113 
 
Sapporo Breweries Limited
 patents
where one patent can have more than one assignee

Years Active: 1993-1997

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5688818 - Succinamic acid compound, production method thereof and use thereof (1997-11-18),
2. 5677300 - Pyridothiazineacetic acid compound, production thereof and use thereof (1997-10-14),
3. 5635505 - 1,4-benzoxazine-2-acetic acid compound, method for production thereof (1997-06-03),
4. 5543420 - Quinoline-3-acetic acid derivative, process for production thereof and (1996-08-06),
5. 5532257 - Benzothiazole compound, production thereof and use thereof (1996-07-02),
6. 5252571 - 1,4-benzothiazine-2-acetic acid derivatives (1993-10-12),

Title: The Innovative Contributions of Yoshiyuki Nakamura

Introduction

Yoshiyuki Nakamura is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in the treatment of diabetes-related complications. With a total of 6 patents to his name, Nakamura's work has garnered attention for its potential impact on healthcare.

Latest Patents

Nakamura's latest patents include innovative compounds such as a succinamic acid compound and a pyridothiazineacetic acid compound. The latter is particularly noteworthy for its application as an aldose reductase inhibitor, which is crucial in preventing and treating complications associated with diabetes. This compound demonstrates an inhibitory action on aldose reductase and is recognized for its superior safety profile. The production method he developed allows for the efficient synthesis of this pyridothiazineacetic acid compound, making it a valuable asset in pharmaceutical formulations aimed at addressing issues like cataracts and neuropathy.

Career Highlights

Throughout his career, Yoshiyuki Nakamura has worked with notable companies such as Senju Pharmaceutical Co., Ltd. and The Green Cross Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.

Collaborations

Nakamura has collaborated with esteemed colleagues, including Tetsuo Matsui and Hiroshi Hosono. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.

Conclusion

Yoshiyuki Nakamura's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving healthcare outcomes. His work continues to influence the development of treatments for diabetes and its complications, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…